The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Agenus Inc | COM | 00847G705 | 1,808,000 | 1,600,000 | SH | Call | SOLE | 1,600,000 | 0 | 0 | |
Agenus Inc | COM | 00847G705 | 15,102,165 | 13,364,748 | SH | SOLE | 13,364,748 | 0 | 0 | ||
Alkermes PLC | SHS | G01767105 | 15,054,367 | 537,464 | SH | SOLE | 537,464 | 0 | 0 | ||
AstraZeneca PLC | SPONSORED ADR | 046353108 | 92,291,254 | 1,362,836 | SH | SOLE | 1,362,836 | 0 | 0 | ||
Axsome Therapeutics Inc | COM | 05464T104 | 5,616,920 | 80,368 | SH | SOLE | 80,368 | 0 | 0 | ||
Celldex Therapeutics Inc | COM | 15117B202 | 11,675,608 | 424,259 | SH | SOLE | 424,259 | 0 | 0 | ||
Celldex Therapeutics Inc | COM | 15117B202 | 5,504,000 | 200,000 | SH | Put | SOLE | 200,000 | 0 | 0 | |
CRISPR Therapeutics AG | NAMEN AKT | H17182108 | 9,078,000 | 200,000 | SH | Put | SOLE | 200,000 | 0 | 0 | |
CymaBay Therapeutics Inc | COM | 23257D103 | 164,606 | 11,040 | SH | Put | SOLE | 11,040 | 0 | 0 | |
Cytokinetics Inc | COM | 23282W605 | 31,232,431 | 1,060,164 | SH | SOLE | 1,060,164 | 0 | 0 | ||
Cytokinetics Inc | COM | 23282W605 | 14,730,000 | 500,000 | SH | Put | SOLE | 500,000 | 0 | 0 | |
Dexcom Inc | COM | 252131107 | 51,333,380 | 550,197 | SH | SOLE | 550,197 | 0 | 0 | ||
Dyne Therapeutics Inc | COM | 26818M108 | 6,138,792 | 685,133 | SH | SOLE | 685,133 | 0 | 0 | ||
Elanco Animal Health Inc | COM | 28414H103 | 40,576,670 | 3,610,024 | SH | SOLE | 3,610,024 | 0 | 0 | ||
Exelixis Inc | COM | 30161Q104 | 19,066,310 | 872,600 | SH | Put | SOLE | 872,600 | 0 | 0 | |
Exelixis Inc | COM | 30161Q104 | 18,152,193 | 830,764 | SH | SOLE | 830,764 | 0 | 0 | ||
Exelixis Inc | COM | 30161Q104 | 874,000 | 40,000 | SH | Put | SOLE | 40,000 | 0 | 0 | |
Geron Corp | COM | 374163103 | 7,849,398 | 3,702,546 | SH | SOLE | 3,702,546 | 0 | 0 | ||
IDEAYA Biosciences Inc | COM | 45166A102 | 27,983,305 | 1,037,187 | SH | SOLE | 1,037,187 | 0 | 0 | ||
IDEXX Laboratories Inc | COM | 45168D104 | 34,055,025 | 77,881 | SH | SOLE | 77,881 | 0 | 0 | ||
Immatics NV | *W EXP 07/01/2025 | N44445117 | 1,128,892 | 318,896 | SH | SOLE | 318,896 | 0 | 0 | ||
Immatics NV | SHS | N44445109 | 37,652,474 | 3,251,509 | SH | SOLE | 3,251,509 | 0 | 0 | ||
ImmunoGen Inc | COM | 45253H101 | 32,457,356 | 2,045,202 | SH | SOLE | 2,045,202 | 0 | 0 | ||
Immunovant Inc | COM | 45258J102 | 5,370,185 | 139,885 | SH | SOLE | 139,885 | 0 | 0 | ||
Inhibrx Inc | COM | 45720L107 | 13,639,445 | 743,294 | SH | SOLE | 743,294 | 0 | 0 | ||
Intuitive Surgical Inc | COM | 46120E602 | 50,647,134 | 173,277 | SH | SOLE | 173,277 | 0 | 0 | ||
Invesco QQQ TR | UNIT SER 1 | 46090E953 | 17,913,500 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
IShares TR | RUSSELL 2000 ETF | 464287655 | 39,766,500 | 225,000 | SH | Put | SOLE | 225,000 | 0 | 0 | |
Karuna Therapeutics Inc | COM | 48576A100 | 115,488 | 683 | SH | SOLE | 683 | 0 | 0 | ||
Kenvue Inc | COM | 49177J102 | 36,185,847 | 1,802,084 | SH | SOLE | 1,802,084 | 0 | 0 | ||
Marinus Pharmaceuticals Inc | COM | 56854Q200 | 2,580,830 | 320,600 | SH | Call | SOLE | 320,600 | 0 | 0 | |
Marinus Pharmaceuticals Inc | COM | 56854Q200 | 7,934,128 | 985,606 | SH | SOLE | 985,606 | 0 | 0 | ||
Merck & Co Inc | COM | 58933Y105 | 74,989,192 | 728,404 | SH | SOLE | 728,404 | 0 | 0 | ||
Mirum Pharmaceuticals Inc | COM | 604749101 | 287,212 | 9,089 | SH | SOLE | 9,089 | 0 | 0 | ||
MoonLake Immunotherapeutics | CLASS A ORD | 61559X104 | 16,689,885 | 292,805 | SH | SOLE | 292,805 | 0 | 0 | ||
Replimune Group Inc | COM | 76029N106 | 5,357,141 | 313,100 | SH | Put | SOLE | 313,100 | 0 | 0 | |
Replimune Group Inc | COM | 76029N106 | 4,277,500 | 250,000 | SH | Call | SOLE | 250,000 | 0 | 0 | |
Replimune Group Inc | COM | 76029N106 | 8,620,771 | 503,844 | SH | SOLE | 503,844 | 0 | 0 | ||
Sanofi | SPONSORED ADR | 80105N105 | 37,299,915 | 695,375 | SH | SOLE | 695,375 | 0 | 0 | ||
Sarepta Therapeutics Inc | COM | 803607100 | 6,194,342 | 51,100 | SH | Call | SOLE | 51,100 | 0 | 0 | |
Savara Inc | COM | 805111101 | 596,892 | 157,908 | SH | SOLE | 157,908 | 0 | 0 | ||
Shockwave Med Inc | COM | Shockwave | 16,201,364 | 81,373 | SH | SOLE | 81,373 | 0 | 0 | ||
SPDR S&P 500 ETF Trust | TR UNIT | 78462F103 | 21,374,000 | 50,000 | SH | Put | SOLE | 50,000 | 0 | 0 | |
Spruce Biosciences Inc | COM | 85209E109 | 131,146 | 58,029 | SH | SOLE | 58,029 | 0 | 0 | ||
Structure Therapeutics Inc | SPONSORED ADS | 86366E106 | 10,190,840 | 202,119 | SH | SOLE | 202,119 | 0 | 0 | ||
Stryker Corporation | COM | 863667101 | 896,052 | 3,279 | SH | SOLE | 3,279 | 0 | 0 | ||
Syndax Pharmaceuticals Inc | COM | 87164F105 | 6,534,000 | 450,000 | SH | Put | SOLE | 450,000 | 0 | 0 | |
Syndax Pharmaceuticals Inc | COM | 87164F105 | 4,356,000 | 300,000 | SH | Call | SOLE | 300,000 | 0 | 0 | |
Syndax Pharmaceuticals Inc | COM | 87164F105 | 13,675,183 | 941,817 | SH | SOLE | 941,817 | 0 | 0 | ||
Syndax Pharmaceuticals Inc | COM | 87164F105 | 4,356,000 | 300,000 | SH | Call | SOLE | 300,000 | 0 | 0 | |
Zentalis Pharmaceuticals Inc | COM | 98943L107 | 24,305,518 | 1,211,641 | SH | SOLE | 1,211,641 | 0 | 0 | ||
argenx SE | SPONSORED ADR | 04016X101 | 38,438,583 | 78,186 | SH | SOLE | 78,186 | 0 | 0 | ||
Aerovate Therapeutics Inc | COM | 008064107 | 51,005,369 | 3,758,686 | SH | SOLE | 3,758,686 | 0 | 0 | ||
Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 70,607,556 | 754,032 | SH | SOLE | 754,032 | 0 | 0 | ||
Bolt Biotherapeutics Inc | COM | 097702104 | 2,864,614 | 2,754,437 | SH | SOLE | 2,754,437 | 0 | 0 | ||
Fusion Pharmaceuticals Inc | COM | 36118A100 | 304,457 | 117,099 | SH | SOLE | 117,099 | 0 | 0 | ||
Galera Therapeutics Inc | COM | 36338D108 | 539,958 | 3,083,712 | SH | SOLE | 3,083,712 | 0 | 0 | ||
Ikena Oncology Inc | COM | 45175G108 | 501,033 | 115,712 | SH | SOLE | 115,712 | 0 | 0 | ||
Inozyme Pharma Inc | COM | 45790W108 | 17,977,294 | 4,280,308 | SH | SOLE | 4,280,308 | 0 | 0 | ||
Karuna Therapeutics Inc | COM | 48576A100 | 233,422,996 | 1,380,466 | SH | SOLE | 1,380,466 | 0 | 0 | ||
Natera Inc | COM | 632307104 | 137,199,780 | 3,100,560 | SH | SOLE | 3,100,560 | 0 | 0 | ||
Nextcure Inc | COM | 65343E108 | 3,446,694 | 2,671,856 | SH | SOLE | 2,671,856 | 0 | 0 | ||
Nucana PLC | SPONSORED ADR | 67022C106 | 3,415,999 | 5,599,999 | SH | SOLE | 5,599,999 | 0 | 0 | ||
Nucana PLC | COMMON SHARES | GB00BYWYV | 1,464,000 | 2,400,000 | SH | SOLE | 2,400,000 | 0 | 0 | ||
PDS Biotechnology Corp | COM | 70465T107 | 720,307 | 142,635 | SH | SOLE | 142,635 | 0 | 0 | ||
RayzeBio Inc | COM | 75525N107 | 53,713,522 | 2,419,528 | SH | SOLE | 2,419,528 | 0 | 0 | ||
Synlogic Inc | COM | 87166L209 | 107,710 | 38,331 | SH | SOLE | 38,331 | 0 | 0 | ||
Vera Therapeutics Inc | CL A | 92337R101 | 47,534,709 | 3,467,156 | SH | SOLE | 3,467,156 | 0 | 0 | ||
Y-mAbs Therapeutics Inc | COM | 984241109 | 11,958,815 | 2,194,278 | SH | SOLE | 2,194,278 | 0 | 0 |